Supriya Lifescience Ltd. has a proven track record of delivering Active Pharmaceutical Ingredients (APIs) and Intermediates to our global clients over 3 decades. Our R&D division partners with innovator and generic companies to develop innovative, cost-effective and safe processes for NCEs, Generic molecules and support life-cycle management of products for global clients.
Our R&D division is approved by the Department of Scientific and Industrial Research (DSIR), Ministry of Science and Technology, Govt. Of India; and has also partnered with internationally acclaimed educational institutes like – The Institute of Chemical Technology, Mumbai.
At Supriya Lifescience Ltd., many hazardous processes are performed at commercial scale which are developed in R&D and successfully scaled up. The complex chemistries are performed in addition to the following range:
